Methamphetamine Use Disorder

The use of lisdexamphetamine was associated with improved outcomes in those with amphetamine and methamphetamine use disorders, researchers reported in JAMA Psychiatry.

In the United States, overdose deaths that involved psychostimulants other than cocaine —mostly methamphetamine — rose 180% in the last 5 full years before the COVID-19 pandemic, a cross-sectional analysis of nationwide data showed.

Responses to combination naltrexone-bupropion therapy among adults with methamphetamine use disorder were “low” but higher than responses to placebo, researchers reported.

Mirtazapine combined with substance use counseling may reduce methamphetamine use and certain HIV risk behaviors among cisgender men and transgender women who have sex with men, according to study findings published in JAMA Psychiatry.